Walder Wyss with Distalmotion on series G funding round
Walder Wyss advised Distalmotion, a globally active MedTech company based in Lausanne, throughout closing of its USD 150 million series G financing round. Revival Healthcare Capital led the funding round in question, with support from inside investor.
The context
The new funding will be mainly directed at accelerating US commercial adoption of Dexter, the company’s soft tissue robotic surgery system, as well as at supporting ongoing clinical and product development initiatives.
The Walder Wyss team
The Walder Wyss corporate and M&A team operated under the leadership of partner Alex Nikitine, managing associate Dimitrios Berger and counsel Iliana Djagova, and included associate Merens Derungs, managing associate Timon Nydegger, senior associate Ken Savioz, senior associate Simon Olstein, as well as trainee lawyers Lia Müller and Dominik Lusti. Moreover, partner André Kuhn advised on notary matters.
